Zobrazeno 1 - 10
of 790
pro vyhledávání: '"Ying Hong Wang"'
Autor:
Karsten Menzel, Yuhsin Kuo, Dapeng Chen, Georgy Hartmann, Ying‐Hong Wang, Carolyn R. Cho, Jacqueline B. McCrea, Kazuhiko Asari
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 6, Pp 1039-1048 (2023)
Abstract Letermovir is approved for use in cytomegalovirus‐seropositive hematopoietic stem cell transplant recipients and is investigated in other transplant settings. Nonlinear pharmacokinetics (PKs) were observed in clinical studies after intrave
Externí odkaz:
https://doaj.org/article/32cc1e5539cc48faa74100d6c7ab7fdf
Autor:
Rebecca M. Klein, Mark E. Layton, Hillary Regan, Christopher P. Regan, Yuxing Li, Tracey Filzen, Matt Cato, Michelle K. Clements, Jixin Wang, Raul Sanoja, Thomas J. Greshock, Anthony J. Roecker, Joseph E. Pero, Ron Kim, Christopher Burgey, Christopher T. John, Ying-Hong Wang, Neetesh Bhandari, Arie Struyk, Richard L. Kraus, Darrell A. Henze, Andrea K. Houghton
Publikováno v:
Channels, Vol 16, Iss 1, Pp 230-243 (2022)
As part of a drug discovery effort to identify potent inhibitors of NaV1.7 for the treatment of pain, we observed that inhibitors produced unexpected cardiovascular and respiratory effects in vivo. Specifically, inhibitors administered to rodents pro
Externí odkaz:
https://doaj.org/article/55057518620746559c951066d12dfcf1
Autor:
Yan-Peng Li, Dilare Adi, Ying-Hong Wang, Yong-Tao Wang, Xiao-Lei Li, Zhen-Yan Fu, Fen Liu, Aibibanmu Aizezi, Jialin Abuzhalihan, Mintao Gai, Xiang Ma, Xiao-mei Li, Xiang Xie, YiTong Ma
Publikováno v:
PeerJ, Vol 11, p e15536 (2023)
Objective The human Disabled-2 (Dab2) protein is an endocytic adaptor protein, which plays an essential role in endocytosis of transmembrane cargo, including low-density lipoprotein cholesterol (LDL-C). As a candidate gene for dyslipidemia, Dab2 is a
Externí odkaz:
https://doaj.org/article/5020e4fba7554056ac93065ba345be38
Autor:
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, Guansheng Liu, Eliford Kitabi, Jianghong Fan, Ying‐Hong Wang, Justin Earp, James L. Weaver, Hao Zhu, Jiang Liu, Kellie S. Reynolds, Shiew‐Mei Huang, Yaning Wang
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 9, Pp 973-982 (2021)
Abstract A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The Anti–SARS‐CoV‐2 Repurposing Drug Database is a database that includes both in vit
Externí odkaz:
https://doaj.org/article/0cb77c809c824b32835bc7a4a70613b8
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
According to authoritative surveys, the overall morbidity and mortality of malignant tumors show an upward trend, and it is predicted that this trend will not be well contained in the upcoming new period. Since the influencing factors, pathogenesis,
Externí odkaz:
https://doaj.org/article/be7ecfba68234456b2b551a14f5a78d8
Autor:
Dilare Adi, Jialin Abuzhalihan, Jing Tao, Yun Wu, Ying-Hong Wang, Fen Liu, Yi-Ning Yang, Xiang Ma, Xiao-Mei Li, Xiang Xie, Zhen-Yan Fu, Yi-Tong Ma
Publikováno v:
Hereditas, Vol 158, Iss 1, Pp 1-9 (2021)
Abstract Background Coronary artery disease (CAD) is the leading cause of death worldwide. In this study, we aimed to explore whether some genetic variants of the human IDOL gene were associated with CAD among Chinese population in Xinjiang. Methods
Externí odkaz:
https://doaj.org/article/4285592623994e9cb00f32670fc0684c
Autor:
Dilare Adi, Jialin Abuzhalihan, Jing Tao, Yun Wu, Ying-Hong Wang, Fen Liu, Yi-Ning Yang, Xiang Ma, Xiao-Mei Li, Xiang Xie, Zhen-Yan Fu, Yi-Tong Ma
Publikováno v:
Hereditas, Vol 158, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/5e96c352ef8a49da9215f962e2a17ec1
Publikováno v:
Molecules, Vol 26, Iss 12, p 3549 (2021)
A simple, rapid, accurate, and selective quantitative method based on 1H nuclear magnetic resonance (qNMR) was successfully established and developed for assessing the purity of dipotassium glycyrrhizinate (KG). In this study, using potassium hydroge
Externí odkaz:
https://doaj.org/article/9d2bccfca3e743859cf43fff7d2d996b
Autor:
R. Angelo De Claro, Marc R. Theoret, Richard Pazdur, Kirsten B. Goldberg, Adam N. Maung, Sherita McLamore, Anamitro Banerjee, Rakhi Shah, Djelila Mezaache, Paresma Patel, Yuching Yang, Lian Ma, Olanrewaju O. Okusanya, Jonathon Vallejo, Soumya Mitra, Ramadevi Gudi, Ying-Hong Wang, Ruo-Jing Li, Alexei Ionan, Robert Q. Le, Donna Przepiorka
On July 16, 2021, the FDA approved belumosudil, a kinase inhibitor, for adult and pediatric patients 12 years and older with chronic GvHD (cGvHD) after failure of at least two prior lines of systemic therapy. Approval was based on the results of Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf5ad9b338cb810d274cde6114ea10c
https://doi.org/10.1158/1078-0432.c.6532340
https://doi.org/10.1158/1078-0432.c.6532340
Autor:
R. Angelo De Claro, Marc R. Theoret, Richard Pazdur, Kirsten B. Goldberg, Adam N. Maung, Sherita McLamore, Anamitro Banerjee, Rakhi Shah, Djelila Mezaache, Paresma Patel, Yuching Yang, Lian Ma, Olanrewaju O. Okusanya, Jonathon Vallejo, Soumya Mitra, Ramadevi Gudi, Ying-Hong Wang, Ruo-Jing Li, Alexei Ionan, Robert Q. Le, Donna Przepiorka
Supplementary Data from FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee0c0967a3851e2bc53147f32148123
https://doi.org/10.1158/1078-0432.22486526
https://doi.org/10.1158/1078-0432.22486526